|
|
|
||||||||||
|
|||||||||||
|
THERAVANCE, INC.
NOMINATING/CORPORATE GOVERNANCE COMMITTEE CHARTER (as adopted by the Board of Directors on May 27, 2004) PURPOSE The purpose of the Nominating/Corporate Governance Committee (the "Committee") of the Board of Directors (the "Board") of Theravance, Inc. (the "Company") shall be to (i) oversee the nomination of directors for service on the Board and its committees and other related matters and (ii) review and consider developments in corporate governance practices and to recommend to the Board a set of effective corporate governance policies and procedures applicable to the Company. The Committee has the authority to undertake the specific duties and responsibilities listed below and will have the authority to undertake such other specific duties as the Board from time to time prescribes. MEMBERSHIP The members of the Committee will by nominated by, will be appointed by, and will serve at the discretion of, the Board and will consist of at least two (2) members of the Board. Each member of the Committee will be an independent director in accordance with the rules promulgated by the Securities and Exchange Commission ("SEC") and The Nasdaq National Market ("Nasdaq"). The Board shall designate one member of the Committee as the Committee's Chairperson. DIRECTOR NOMINATION POLICY The Committee has been established to serve the interests of the Company and its stockholders to obtain highly qualified candidates with the personal integrity, knowledge, skills, expertise, diversity of experience, ability to make independent analytical inquiries, understanding of the Company's business environment and willingness to devote adequate time and effort to serve as members of the Board. RESPONSIBILITIES AND AUTHORITY The responsibilities and authority of the Committee shall include: Board and Committee Nomination and Evaluation
Corporate Governance
INVESTIGATIONS, STUDIES AND OUTSIDE ADVISORS The Committee may conduct or authorize investigations into or studies of matters within the Committee's scope of responsibility with full access to all books, records, facilities and personnel of the Company. As appropriate, the Committee will obtain advice and assistance from outside legal, accounting or other advisors at the Company's expense. MEETINGS The Committee will determine its own schedule and will meet at least one (1) time each year. The Committee may take action by unanimous written consent. MINUTES The Committee will maintain written minutes of its meetings, which minutes will be filed with the minutes of the meetings of the Board. REPORTS The Committee will provide reports to the Board regarding the Committee's nominations for election to the Board and its committees and regarding such other matters as the Committee may deem appropriate. COMPENSATION Members of the Committee shall receive such fees, if any, for their service as Committee members, as may be determined by the Board. Such fees may include retainers or per meeting fees and shall be paid in such form of consideration as is determined by the Board in accordance with the applicable rules of Nasdaq and the SEC. DELEGATION OF AUTHORITY The Committee may, to the extent permitted under applicable law, the rules of Nasdaq and the SEC, and the Company's Certificate of Incorporation and Bylaws, form and delegate authority to subcommittees when appropriate. |
||||||||||
| ©2008 Theravance, Inc. Theravance, the Theravance logo and Medicines That Make a Difference are
registered trademarks of Theravance, Inc. Trademarks, trade names or service marks of other companies appearing on this
website are the property of their respective owners. All rights reserved.
Terms of Use Website Admin Contact Theravance Contact Site Map |
|||||||||||